Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2009 3
2010 4
2011 4
2012 6
2013 3
2014 11
2015 13
2016 16
2017 19
2018 16
2019 17
2020 17
2021 26
2022 13
2023 10
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Skin Barrier Function and the Microbiome.
Lee HJ, Kim M. Lee HJ, et al. Among authors: kim m. Int J Mol Sci. 2022 Oct 28;23(21):13071. doi: 10.3390/ijms232113071. Int J Mol Sci. 2022. PMID: 36361857 Free PMC article. Review.
Angiogenesis in Chronic Inflammatory Skin Disorders.
Lee HJ, Hong YJ, Kim M. Lee HJ, et al. Among authors: kim m. Int J Mol Sci. 2021 Nov 7;22(21):12035. doi: 10.3390/ijms222112035. Int J Mol Sci. 2021. PMID: 34769465 Free PMC article. Review.
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.
Muppidi S, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Nowak RJ, Andersen H, Casasnovas C, de Bleecker JL, Vu TH, Mantegazza R, O'Brien FL, Wang JJ, Fujita KP, Howard JF Jr; Regain Study Group. Muppidi S, et al. Muscle Nerve. 2019 Jul;60(1):14-24. doi: 10.1002/mus.26447. Epub 2019 Mar 8. Muscle Nerve. 2019. PMID: 30767274 Free PMC article.
Subungual osteochondroma.
Hwang S, Kim M, Park HJ. Hwang S, et al. Among authors: kim m. Indian J Dermatol Venereol Leprol. 2017 Sep-Oct;83(5):620-621. doi: 10.4103/ijdvl.IJDVL_931_16. Indian J Dermatol Venereol Leprol. 2017. PMID: 28474643 Free article. No abstract available.
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma.
Bollu LR, Bommi PV, Monsen PJ, Zhai L, Lauing KL, Bell A, Kim M, Ladomersky E, Yang X, Platanias LC, Matei DE, Bonini MG, Munshi HG, Hashizume R, Wu JD, Zhang B, James CD, Chen P, Kocherginsky M, Horbinski C, Cameron MD, Grigorescu AA, Yamini B, Lukas RV, Schiltz GE, Wainwright DA. Bollu LR, et al. Among authors: kim m. J Med Chem. 2022 Dec 8;65(23):15642-15662. doi: 10.1021/acs.jmedchem.2c00771. Epub 2022 Nov 21. J Med Chem. 2022. PMID: 36410047 Free PMC article.
Alitretinoin for Hypertrophic Lichen Planus.
Yoo SA, Park HE, Kim M. Yoo SA, et al. Among authors: kim m. Ann Dermatol. 2022 Jun;34(3):235-236. doi: 10.5021/ad.2022.34.3.235. Epub 2022 May 20. Ann Dermatol. 2022. PMID: 35721329 Free PMC article. No abstract available.
161 results